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The in vivo immunomodulatory eﬀe c to fe t h a n o l i ce x t r a c t sf r o ml e a v e so fRhaphidophora korthalsii was determined via immune
cellproliferation,T/NKcellphenotyping,andsplenocytecytotoxicityofBALB/cmiceafter5consecutivedaysofi.p.administration
at various concentrations. Splenocyte proliferation index, cytotoxicity, peripheral blood T/NK cell population, and plasma
cytokine (IL-2 and IFN-γ) in mice were assessed on day 5 and day 15. High concentration of extract (350μg/mice/day for 5
consecutivedays)wasabletostimulateimmunecellproliferation,peripheralbloodNKcellpopulation,IL-2,andIFN-γ cytokines,
aswellassplenocytecytotoxicityagainstYac-1cellline.UnlikerIL-2whichdegradedrapidly,thestimulatoryeﬀectfromtheextract
managed to last until day 15. These results suggested the potential of this extract as an alternative immunostimulator, and they
encourage further study on guided fractionation and puriﬁcation to identify the active ingredients that contribute to this in vitro
and in vivo immunomodulatory activity.
1.Introduction
Since ancient times, the use of healing properties of plant
extract has been common practice. Many people have started
to use fresh plant products like fruits and vegetables in their
daily meals and traditional herbs in diﬀerent value-added
processed forms (extracts, powders, pills, and decoction) as a
daily food supplement to improve human health [1]. Among
these, natural botanical sources that serve as potential
immunostimulators have received much attention for their
low toxicity and bioavailability [2]. Researchers have started
to study the immunostimulatory eﬀect of traditional herbs
to supplement the traditional usage of these plants or herbs
withascientiﬁcbasis.Rhaphidophorakorthalsii(Araceae)isa
largegenusofaclimbingshrubdistributedthroughoutIndia,
Sri Lanka, Cambodia, Venezuela, Malaysia, Australia, and
Indonesia [3]. It is better known as dragon tail in Malaysia
and Singapore and is commonly used in traditional Chinese
herbal medicine for cancer and skin disease treatment [4].
Various extracts of R. korthalsii traditionally used for cancer
treatment have been shown by researchers to exert cytotoxic
eﬀect on various cancerous cell lines [4, 5]. This eﬀect
was mainly driven by the presence of 5,6-dihydroxyindole
(DHI) which showed cytotoxic activity against p388 and
nonmelanocytic cancerous cell line [6]. Additionally, studies
have also shown that an R. korthalsii methanol extract2 Evidence-Based Complementary and Alternative Medicine
stimulated proliferation of mice splenocytes and human
PBMC [4, 7]. As a result, they concluded that this plant
extractmaybeusefulin boosting theimmune systemtoﬁght
various diseases including cancer. However, the potential
of the extract to stimulate in vivo immune function is still
unclear. The present study aims to evaluate the in vivo eﬀects
of R. korthalsii on BALB/c mice in comparison with in vitro
immunomodulatory eﬀects of the extract in human PBMC.
2.MaterialsandMethods
2.1. Materials and Reagents. Recombinant murine inter-
leukin 2 (rmIL-2; Dako, USA) was used as a positive con-
trol. This commercial immunomodulator was prepared by
dissolving it directly into the culture media DMEM (Sigma,
USA) at a concentration of 10,000U/mL. Fluoroisothiocy-
anate- (FITC-) labeled CD3 antigoat monoclonal antibody
andphycoerythrin-(PE-)labeledCD56antigoatmonoclonal
antibody were purchased from Biolegend, USA.
2.2. Plant Material and Extraction. Leaves of R. korthalsii
were collected from Georgetown, Penang in June 2006, and
were identiﬁed by Mr. Lim Chung Lu (Kepong, Selangor)
from the Forestry Division of the Forest Research Institute
of Malaysia (FRIM, Malaysia). The voucher number of R.
korthalsii is FRIM 33687. Leaves of the plant were air-dried
in shade and ﬁnely powdered. Leaf extract was prepared by
soaking the leaf powder in 250mL of methanol (J.T. Baker,
USA) for 72 hours. The extract was ﬁltered with Whatman
ﬁlter paper number 1 and evaporated to dryness under
reduced pressure using Aspirator A-3S (EYELA, Japan) at
<40◦C. The process was repeated three times (yield 27.3%,
w/w). The dried residue was resuspended in DMSO (Fisher
Scientiﬁc, UK) at a concentration of 10mg/mL as a plant
extractstock.Asubstocksolutionof0.2mg/mLwasprepared
bydiluting20μLofthestocksolutioninto980μLserum-free
culture medium (the percentage of DMSO in the experiment
should not exceed 0.5). The stock and substock solutions
were both stored at 4◦C.
2.3. Animals. Balb/c mice, 8 weeks old, were used in this
experiment. The animals were purchased from Animal
House, Institute for Medical Research (IMR, Kuala Lumpur,
Malaysia) and were housed under standard conditions at 25
± 2◦C, fed with standard pellets and tap water. This work
wasapprovedbyAnimalCareandUseCommittee,Universiti
Putra Malaysia (UPM; Ref: UPM/FPV/PS/3.2.1.551/AUP-
R2).
2.4. In Vivo Stimulation of Mice with R. korthalsii . Eight-
week-old Balb/c mice ranging from 19 to 20g were selected
for this study, where duplicate treatment groups were
conducted, but sacriﬁced on diﬀerent days (D6 and D16).
I ne a c hg r o u p ,s i xs e t so fm i c ei ng r o u p so fﬁ v ew e r ei . p .
injected daily in the morning with either R. korthalsii extract
(25, 200, 350, 700μg/mouse in 0.2mL PBS), IL-2 (50U in
0.2mL PBS), or just 0.2mL PBS for 5 days. Then, on day 6
of the study, the ﬁrst group of animals was sacriﬁced while
the second group was observed for 10 days and sacriﬁced on
day 16 (Figure 1). Mice were anesthetised with 2% isoﬂurane
(Merck) and sacriﬁced by cervical dislocation. Thus, all
together, 60 mice were used in this study.
2.5.ExVivoStimulationintheProliferationResponseofSpleen
Cells. For ex vivo proliferation experiments, splenocytes and
bone marrow monocyte from both day 6 and day 16 mice
injected with R. korthalsii methanol extract were collected.
Brieﬂy, the spleen was removed and quickly washed with
Hank’s Balanced Salts Solution (HBSS), minced, and pressed
through80μmsterilewiremeshscreenwitharubbersyringe
plunger. Added to this, femur was removed from mice,
epiphysis was cut, and the bone marrow was triturated
using an 18-gauge needle with HBSS and passed through
80μm sterile wire mesh. Both types of cell suspension
were washed once with PBS supplemented with 0.1% BSA
and 2mg/mL EDTA (PBS-BSA-EDTA) and spun down at
200g for 10 minutes. After that, red blood cells were
removed by incubating and washing with lysis buﬀer (8g
NH4Cl, 1g Na2EDTA, 0.1g KH2PO4, pH 7.4). This step was
repeated until the pellet was clean. Then, the cell suspension
was washed a ﬁnal time with PBS-BSA-EDTA, spun, the
supernatant discarded, and the cell pellet was resuspended
in 4mL of Dulbecco’s Modiﬁed Eagle Medium (DMEM)
with 10% heat inactivated FBS. Cell counting was then
performed to determine the lymphocyte cell number in the
suspension. All of the steps above were carried out under
sterile conditions in biological safety cabinet to prevent any
contamination. Splenocyte cell viability for all treatment
groups was determined after stimulation with R. korthalsii
extract (25μg/mL), IL-2 (50U/mL), or vehicle control and
further incubation at 37◦C, 5% CO2 for 72 hours. After this
period, cells were harvested and cell growth was tested using
MTT cell viability assay in triplicate in 96-well ﬂat bottom
plates. Brieﬂy, 20μLo fM T T( S i g m a ,U S A )a t5m g / m Lw a s
addedintoeverywellandtheplatewasincubatedforanother
four hours at 37◦C. Then, the plate was centrifuged at 200
×g for 5min, and 170μL of supernatant was aspirated from
every well. The resulting formazan crystals were solubilized
by 100μL of DMSO (Fisher Scientiﬁc, UK) in each well
followed by incubation for 20 minutes at 37◦C. Finally, the
plate was read at 570nm and 630nm as reference wavelength
by using μ Quant ELISA Reader (Bio-tek Instruments, USA).
The percentage of cell viability was calculated using the
following formula:
Percentage of cell viability =
OD sample
OD control

× 100. (1)
2.6. In Vivo Mice Blood NK Cell Immunophenotyping. Blood
was collected in heparinized tuberculin syringes via cardiac
puncture and was washed three times with PBS-BSA-EDTA.
Fifty μL of the blood was resuspended with 500μLo f
lysing buﬀer (BD, USA) and 10μg/10μLF I T Cc o n j u g a t e d
antimouse CD3 (17A2; isotype control: IgG2b, κ; Biolegend,
USA) and 12.5μg/10μL PE conjugated antimouse NK-1.1
antibodies (PK136; isotype control: IgG2a, κ; Biolegend,
USA). After that, cells were washed three times (300g,Evidence-Based Complementary and Alternative Medicine 3
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Figure 1: The general time course of the in vivo studies. The time
of repletion and immune response assays varied somewhat among
experiments. Animals were injected with extract, mouse rIL-2, or
normal saline (for control group) for 5 days. Half of the animals
(total of 30 mice) were sacriﬁced on days 6 and the remaining
animals (the remaining 30 mice) were sacriﬁced on day 16.
10 minutes) and resuspended in PBS-BSA-EDTA at a ﬁnal
volume of 1mL for ﬂowcytometric analysis using a FAC-
SCalibur ﬂowcytometer with CellQuest Pro software (BD
Bioscience, USA).
2.7. In Vivo Mice Blood IL-2 and IFN-γ Determination.
Blood was collected using cardiac puncture, placed into
heparin tubes, and spun down at 8000g for 5 minutes. The
translucentbloodplasmaswascollectedfromtheupperlayer
a n ds t o r e da t−20◦C until future analysis. The concentration
of IL-2 and IFN-γ in plasma was determined by using
murine Cytokine Instant Enzyme Link Immunosorbent
Assay (ELISA) kit (BioLegend, USA). Brieﬂy, capturing
antibody speciﬁc to murine IL-2 or IFN-γ was coated onto
the wells of the microtitre strips provided one day before the
assay at 4◦C. Then, 100μL of diluted IL-2 or IFN-γ standard
(range from 125μgt o2 μg) and plasma were added into
the precoated microtitre plate and incubated for 2 hours
at room temperature. The plates were then washed and
100μL of diluted biotinylated detection antibody was added
and incubated for 2h. Imaging step included Avidin-Horse
Radishperoxidaseand3,3 ,5,5  tetramethylbenzidine(TMB)
as chromogen. OD was read immediately at 450nm wave-
length using μ Quant ELISA Reader (Bio-Tek Instruments,
USA)atAnimalTissueCultureLaboratory,FBBS,UPM.The
result was compared to the control prepared simultaneously.
Each plasma from either treated or nontreated animals was
assayed three times. Data are expressed as pg/mL.
2.8. In Vivo Induction of Mice Splenocytes Cytotoxicity.
Splenocytes (Eﬀector-E) were harvested from the control,
IL-2, and extract treated animals, and the cytotoxicity of
splenocytes towards Yac-1 (Target-T) cell line was deter-
mined using CytoTox 96 nonradioactive cytotoxicity assay
k i t( P r o m e g a ,U S A )a tt h er a t i oo fe ﬀector:target of 2:1;
10:1, and 50:1 and incubated in 37◦C, 5% CO2, and 90%
humidity for 24 hours. Splenocyte with the cell concentra-
tion equivalent to each ratio in the coculture experimental
well (eﬀector spontaneous LDH release) and Yac-1 with the
cell concentration equivalent to the coculture experimental
well (for both target spontaneous LDH release and target
maximum LDH release by the lysis solution) were prepared
simultaneously. Brieﬂy, 45 minutes prior to the ending of
coculture incubation period, 10μL of Triton-X lysis solution
(10X) was added into the target Yac-1 cell maximum LDH
release control wells. The plate was further incubated for
45 minutes until the target cells maximum LDH release
controlwascompletelylysed.Then,theplatewascentrifuged
(250g, 4 minutes), and 50μL of supernatant from each well
was transferred to a new 96-well plate (BD Biosciences,
USA). The substrate mixture was prepared simultaneously
by reconstituting one vial of substrate mixing with 12mL
of assay buﬀer. After that, 50μL of reconstituted substrate
mixture was added into all the experimental wells and
incubated for 30 minutes in the dark. Finally, 50μLo f2 . 5N
sulfuric acid stop solution was added into each well and the
plate was read at 490nm wavelength immediately by using
μ Quant ELISA Reader (Bio-Tek Instruments, USA). LDH
converts substrate mixture into a yellow formazan product.
The intensity of color formed (recorded as absorbance
at 496nm) is proportional to the number of lysed cells.
Percentage of LDH release was calculated using the following
formula:
Percentage of Cytotoxicity
=
OD sample − OD target spontaneous
OD target maximum −OD target spontaneous
−
OD eﬀector spontaneous
OD target maximum −OD target spontaneous
× 100.
(2)
2.9. Statistical Analysis. Results are expressed as Mean ±
Standard Error (SEM). Diﬀerences between means were
evaluated using ANOVA test (one way) followed by Duncan
test, and P ≤ 0.05 was taken as statistically signiﬁcant.
3. Results
3.1. In Vivo Stimulation of Mice. In view of the signiﬁcant
in vitro stimulatory activity by R. korthalsii [4, 7], it was of
interesttodetermineifthisactivitywouldtranslateintoanin
vivo eﬀect. In order to assess the in vivo immunoregulatory
eﬀect of R. korthalsii methanol extract, 60 mice weighing
approximately 19-20g were divided into 12 groups and were
injected with diﬀerent concentration of extract or positive
control. Mice weighed between 23 to 25g after day 5 of
injectionand28to30gafterday15ofﬁrstinjection.Noneof
the animals died during the experimental period, and there
were no diﬀerences in activity between the untreated and
treated mice.
3.2. Ex Vivo Splenocyte and Bone Marrow Proliferation. The
ex vivo proliferation assay is an in vitro assessment which
allows the study of in vivo splenocyte proliferation after
being treated with the immunomodulator [8]. The in vitro
proliferation response of splenocytes and bone marrow
cultures was investigated 72 hours after harvesting from4 Evidence-Based Complementary and Alternative Medicine
animals by treatment with test extract, positive, and negative
controls. After 5 days of in vivo treatment with the 2 high
concentrations of extract (350 and 700μg/mice) or rIL-2,
ex vivo stimulation with extract or rIL-2 greatly increased
the proliferation response of splenocytes and bone marrow
cells (Table 1). In contrast, low concentration of extract
(25 and 200μg/mice) groups responded to in vitro extract
and rIL-2 stimulation quite similar to the splenocytes and
bone marrow cells isolated from the control group. This
could be because the extract concentration is too low to
initiate the indirect mitogenic eﬀect towards the immune
cells in vivo. Recombinant IL-2 was suﬃcient to induce
cell growth in both splenocytes and bone marrow with or
without the ex vivo stimulation. The mice injected with high
concentration (350 and 700μg/mice) extract showed the
greatest eﬀect on splenocyte and bone marrow cells growth.
Ex vivo stimulation on the high concentration extract treated
mice exhibited marked increase of both splenocytes and
bone marrow cell growth, even compared to the optimum
stimulation(25μg/mL)eﬀectonthesametypeofcellinvitro
in a previous report [7]. After day 15, there was no major
diﬀerenceforthecellgrowthresponsewhencomparedtoday
5inthehighdoseextract-treatedmice.However,forthemice
injected with rIL-2, there was a marked decrease of ex vivo
cell growth in both splenocytes and bone marrow cell from
day 6 to day 16. This may be due to the in vivo degradation of
rIL-2 10 days after the injection. Thus, both the extract and
rIL-2 were able to promote the immune cell growth not only
in vitro, but also in vivo and ex vivo.
3.3. In Vivo Blood NK Cell Immunophenotyping. In order to
understand the in vivo stimulatory eﬀect of the extract on
NK cells population, NK cell immunophenotyping was per-
formed(Figure 2).Theperipheralbloodofmicetreatedwith
extract or rIL-2 was found to increase the cell population
withNK1.1phenotypeascomparedwithnontreatedcontrol
mice. The increase was found only by using rIL-2 and
high concentrations (350 and 700μg/mice) of R. korthalsii
methanol extract but not with the mice treated with lower
concentration (25 and 200μg / m i c e )o fe x t r a c t .T h ei n c r e a s e
in cell population with NK1.1 phenotype was maintained
until day 15 without signiﬁcant reduction.
3.4. In Vivo Blood Cytokine ELISA Test. In vivo study
results were in concordance with the in vitro study where
both extract and mouse rIL-2 were able to stimulate the
production of cytokines. Figure 3 illustrates the cumulative
amount of rIL-2 and IFN-γ in the blood after the treatment.
Mouse rIL-2 was not used as positive control in the rIL-
2 ELISA test to avoid false positives given by the injection.
Mice treated with 700 and 350μg/mice of extract showed
approximately 2- to 3.5-fold higher levels of IL-2 and IFN-
γ detected in blood plasma. On the other hand, the low
concentration (25 and 200μg/mice) of extract did not show
signiﬁcant diﬀerences for either cytokines detected in blood
plasma as compared to untreated mice at day 5 or 15 mice.
Mouse rIL-2 treatment produced the highest level of IFN-γ
detected in blood plasma as compared to all concentration of
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Figure 2: NK cell immunophenotyping on mice blood after being
treated with various concentration of R. korthalsii methanol extract
or mice rIL-2 for day 6 and day 16 in vivo. Each value represents
the means ± SEM for three assays in duplicate each. The diﬀerences
between the control group and treated group were determined by
one-way ANOVA (∗P ≤ 0.05).
extract. However, both treatments also induced lower level
of cytokines detected in blood plasma when compared to the
in vitro splenocytes cytokines production. Day 5 and day 15
contained similar a level of cytokines detected in the blood
plasma and gave the idea that both treatment lasted from day
5 until day 15.
3.5. In Vivo Mice Splenocytes Cytotoxicity Assay. The result of
in vivo induction of splenocyte activity by extract and rIL-
2 is shown in Figure 4. Cytotoxicity of untreated and low
concentration (25 and 200μg/mice) extract treated spleno-
cytes were quite similar where we measured an increase from
approximately 20% to 40–50% cytotoxicity when increasing
the splenocyte cell number in the coculture. This result
was similar on both day 6 and day 16 mice. On the other
hand, mice treated with a high concentration of extract
demonstrated an enhanced splenocyte cytotoxicity, even at
low ratio of eﬀector cells at both time points. Although the
rIL-2showedasimilareﬀectonsplenocytecytotoxicitywhen
compared to high concentrations of R. korthalsii methanol
extract, it was short term since the eﬀect in day 16 mice
dropped to a level same as the control group while the
extractstillexhibitedastrongstimulativeeﬀectonsplenocyte
cytotoxicity. From this result, R. korthlasii methanol extract
wasfoundtoenhancethesplenocytescytotoxicityinvivoand
was longer lasting when compared to rIL-2.
4. Discussion
Searching for substances with immunostimulative or
immunorestorative eﬀects could contribute to the
maintenance of the immune system, which may prevent
the progression of tumour establishment [9]. Evaluation of
immune cells, especially bone marrow cells and splenocyte
proliferation, is typical when screening for potential
immunomodulatory eﬀects of a substance [10].Evidence-Based Complementary and Alternative Medicine 5
Table 1: Mice splenocytes harvested after day 5 or day 15 of treatment were allowed to proliferate with or without the treatment of R.
korthalsii (25μg/mL) or mouse rIL-2 (50U/mL). The rate of cell viability was evaluated using MTT cell viability assay∗.
Untreated R. korthalsii (25μg/mL) Mouse rIL-2 (50U/mL)
Splenocytes
(%)
Bone marrow
(%)
Splenocytes
(%)
Bone marrow
(%)
Splenocytes
(%)
Bone marrow
(%)
Control
5 day 100 100 172 ± 1.3 152 ± 2.6 186 ± 2.1 160 ± 3.2
15 day 100 100 168 ± 2.1 154 ± 2.3 179 ± 3.4 159 ± 2.1
R. korthalsii (25μg/mice)
5 day 104 ± 1.6 106 ± 1.3 178 ± 2.7 147 ± 1.4 184 ± 1.6 158 ± 2.7
15 day 102 ± 1.1 107 ± 2.5 174 ± 1.5 149 ± 1.9 187 ± 1.8 162 ± 2.8
R. korthalsii (200μg/mice)
5 day 113 ± 1.2 107 ± 2.4 184 ± 3.2 159 ± 2.7 192 ± 3.4 163 ± 1.8
15 day 118 ± 1.6 110 ± 2.5 180 ± 2.7 151 ± 1.7 195 ± 2.3 171 ± 1.9
R. korthalsii (350μg/mice)
5 day 154 ± 1.8∗ 161 ± 2.8∗ 247 ± 2.9∗ 201 ± 4.8∗ 253 ± 4.1∗ 214 ± 3.7∗
15 day 151 ± 2.1 168 ± 3.4 241 ± 3.2 213 ± 3.6 258 ± 4.7 209 ± 4.2
R. korthalsii (700μg/mice)
5 day 146 ± 2.3∗ 137 ± 2.4∗ 225 ± 3.4∗ 187 ± 3.1∗ 241 ± 3.5∗ 193 ± 3.1∗
15 day 142 ± 1.5 141 ± 2.3 233 ± 4.6 192 ± 4.2 245 ± 3.7 204 ± 2.5
Mice rIL-2 (50U/mice)
5 day 143 ± 2.1∗ 172 ± 4.3∗ 259 ± 4.2∗ 211 ± 4.9∗ 267 ± 3.3∗ 219 ± 1.8∗
15 day 124 ± 2.7 121 ± 2.6 197 ± 3.5 184 ± 5.1 207 ± 3.5 192 ± 1.9
∗Note:thevaluesarethemeans ±SEofthreeexperiments.Thediﬀerencesbetweenthecontrolgroupandtreatedgroupweredeterminedbyone-wayANOVA
(∗P ≤ 0.05).
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Figure 3: Eﬀects of R. korthalsii methanol extract on cytokine production in vivo. The serum concentrations of IL-2 and IFN-γ were tested
by ELISA assay. (a) Concentration of IL-2 in vivo. (b) Concentration of IFN-γ in vivo. Each value represents the means ± SEM for three
assays in duplicate each. The diﬀerences between the control group and treated group were determined by one-way ANOVA (∗P ≤ 0.05).
In vivo study using small animals to substitute for human
trialcanprovideabetterunderstandingoftheimmunomod-
ulator toward the immune system as compared to the single-
cell type in vitro studies [11–13]. For example, Kagi et al.
[14] showed the importance of the pore-forming protein-
perforin for in vivo antitumour eﬀects using perforin-
deﬁcient mice. Besides, animal experiments have also been
used to demonstrate the ability of raw herbs or some of
theirpuriﬁedcomponentstoinhibittumourgrowththrough
activation of the immune system [15, 16] or suppress the
immune system [17].
Since previous study showed that continuous IL-2
administration was more eﬀective to prolong augmentation
of NK cell competence in vivo, we selected 5 days of repeated6 Evidence-Based Complementary and Alternative Medicine
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Figure 4: Viability of Yac-1 after being treated with diﬀerent ratio of R. korthalsii extract or mouse rhIL-2-activated splenocytes in vivo (a)
after day 5 of treatment and (b) after day 15 of treatment. Each value represents the means ± SEM for three assays in triplicate each. The
diﬀerences between the control group and treated group were determined by one-way ANOVA (∗P ≤ 0.05).
injections of R. korthalsii methanol extract or IL-2 treatment
for the in vivo portion of our study [18]. Various concen-
trations of extract were evaluated, and results showed that
low concentrations (25 and 200μg/mice) were insuﬃcient
to induce statistically signiﬁcant immunomodulatory eﬀects
in vivo. On the other hand, higher concentrations (350 and
700μg/mice) showed signiﬁcant immunostimulatory eﬀects,
as reported in the previous in vitro study by Yeap et al. [7].
The results of this study indicated the optimum concen-
tration was 350μg/mouse/day, as the immunomodulatory
eﬀects in the 700μg/mouse/day group were slightly reduced
in comparison.
From the ex vivo proliferation results, restimulation
of the spleen cells with either extract or cytokine further
enhanced the eﬀect by both extract and rIL-2. This may
be due to the “priming” eﬀect brought about by the i.p.
injections of the extract or cytokine. In the ex vivo bone
marrow cells, higher growth rates were recorded after the 72
hoursstimulationwhencomparedtotheinvitrocellviability
results. This result may also be due to the contribution of
“priming” eﬀect of the extract or rIL-2 injection. Added
to this, activation of NK cells may also contribute to
better stimulation of bone marrow cell growth. NK cells
have long been thought to regulate hematopoiesis [19].
Activation of NK cells with rIL-2 was found to support
hematopoietic growth of bone marrow cells without any
hematopoietic growth factors [20]. The in vitro cell viability
study only involves the single-cell type with extract and
does not account for the interaction of activated NK cells to
stimulate bone marrow cell growth. Unlike the in vitro study,
the ex vivo study involves more elements of the immune
system with the presence of extract or rIL-2-activated NK
cells, which may also further help to promote the maturation
and proliferation of the hematopoietic cells in vivo.
In vivo splenic cytotoxic NK cells’ activity was evaluated
by cocultivation of isolated splenocytes with the NK cell
sensitive Yac-1 target. The results showed that the in vivo
mouse model for immune cell cytotoxicity to target Yac-1
cells was dose dependent and statistically signiﬁcant with
respect to the control in the groups treated with extract.
The results obtained in the present study showed that both
treatmentperiodsdisplayedadose-dependentimmunostim-
ulatory eﬀect which can last until day 15. However, rIL-2 was
lessdurableascomparedtotheextractathighconcentration.
This may due to the rapid clearance of the protein from
thesystemiccirculationfollowingadministrationtothemice
[21].
Previous studies [4, 7, 22] have reported on the stimula-
tion of in vitro human PBMC and mice splenocytes cell by
R. korthalsii methanol extract. Similar patent of stimulation
of immune cell proliferation and cytokines (IL-2 and IFN-
γ) secretion have been discovered in this in vivo study. IL-
2a n dI F N - γ is a type of cytokine that plays an important
role to inhibit tumor formation. IL-2 was able to stimulate
NK cell while IFN-γ was secreted by the activated NK cell
[7, 23]. Thus, the potential of R. korthalsii methanol extract
on stimulation of immune cell IL-2 secretion may be the
major contributor of raise of IFN-γ producing NK cell
population in the peripheral blood. Extract-activated NK
cells may further contribute to the suppression of tumor cellEvidence-Based Complementary and Alternative Medicine 7
lines (Yac-1, HepG2, and K562) as reported in the above
results or the previous studies [7, 22].
In this study, stimulation of the immune system by
R. korthalsii methanol extract had signiﬁcant eﬀects on
proliferation, NK cell population, and cytokine expression
in the host, which further enhanced the cytolytic activity of
the immune cells. Up till now, 5,6-dihydroxyindole (DHI) is
the only compound successfully isolated from R. korthalsii.
However, role of DHI on the immunomodulatory eﬀect
of R. korthalsii methanol extract and the other potential
active secondary metabolites that play an important role
in this immunostimulatory eﬀect are still unknown. Thus,
future study should focus on isolation and evaluation of
active metabolites from the extract that contributes to the
immunomodulatory eﬀect against the NK cell.
References
[1] G. E. Thomson, The Health Beneﬁts of Traditional Chinese
Plant Medicines: Weighing the Scientiﬁc Evidence: A Report for
the Rural Industries Research and Development Corporation,
RIRDC, Barton, Australia, 2007.
[2] B. J. Darien and R. G. Godbee, “Morinda citrifolia based
formulations for regulating T cell immunomodulation in
neonatal stock animals,” USA Patent 20090068204, 2009.
[3] K. R. Kiritikar and B. D. Basu, Indian Medical Plant with
Illustration, vol. 11, Oriental Enterprises, Dehradum, India,
2nd edition, 2001.
[4] K. T. Wong and B. K. H. Tan, “In vitro cytotoxicity and
immunomodulating property of Rhaphidophora korthalsii,”
Journal of Ethnopharmacology, vol. 52, no. 1, pp. 53–57, 1996.
[5] M. L. Tan, T. S. T. Muhammad, N. Najimudin, and S. F.
Sulaiman, “Growth arrest and non-apoptotic programmed
cell death associated with the up-regulation of c-myc mRNA
expression in T-47D breast tumor cells following exposure to
Epipremnum pinnatum (L.) Engl. hexane extract,” Journal of
Ethnopharmacology, vol. 96, no. 3, pp. 375–383, 2005.
[6] M. Toyota and M. Ihara, “Recent progress in the chemistry
of non-monoterpenoid indole alkaloids,” Natural Product
Reports, vol. 15, no. 4, pp. 327–340, 1998.
[ 7 ]S .K .Y e a p ,N .B .A l i t h e e n ,A .M .A l ie ta l . ,“ E ﬀect of Rhaphi-
dophora korthalsii methanol extract on human peripheral
blood mononuclear cell (PBMC) proliferation and cytolytic
activity toward HepG2,” Journal of Ethnopharmacology, vol.
114, no. 3, pp. 406–411, 2007.
[8] J. Heaney, S. L. Cosby, and T. Barrett, “Inhibition of host
peripheral blood mononuclear cell proliferation ex vivo by
Rinderpest virus,” Journal of General Virology, vol. 86, no. 12,
pp. 3349–3355, 2005.
[9] S. Kadhim, C. Penney, M. Lagraoui et al., “Synergistic anti-
tumor activity of a novel immunomodulator, BCH-1393, in
combinationwithcyclophosphamide,”InternationalJournalof
Immunopharmacology, vol. 22, no. 9, pp. 659–671, 2000.
[10] Y. Seo, H. J. Lee, Y. Kim, H. Youn, and B.-J. Lee, “Eﬀects of
several salt marsh plants on mouse spleen and thymus cell
proliferation using MTT assay,” Ocean Science Journal, vol. 40,
no. 4, pp. 209–212, 2005.
[11] M. Levin, H. Leibrecht, J. Ryan, F. Van Dolah, and S. De Guise,
“Immunomodulatory eﬀects of domoic acid diﬀer between in
vivo and in vitro exposure in mice,” Marine Drugs, vol. 6, no.
4, pp. 636–659, 2008.
[12] R.L.White,“Whatinvitromodelsofinfectioncanandcannot
do,” Pharmacotherapy, vol. 21, no. 11, part 2, pp. 292S–301S,
2001.
[13] E. Traggiai, L. Chicha, L. Mazzucchelli et al., “Development of
a human adaptive immune system in cord blood cell-trans-
planted mice,” Science, vol. 304, no. 5667, pp. 104–107, 2004.
[14] D. Kagi, B. Ledermann, K. Burki et al., “Cytotoxicity mediated
by T cells and natural killer cells is greatly impaired in
perforin-deﬁcientmice,” Nature,vol.369,no.6475,pp.31–37,
1994.
[15] Z.M.Hassan,R.Yaraee,N.Zare,T.Ghazanfari,A.H.S.Nejad,
and B. Nozari, “Immunomodulatory aﬀect of R10 fraction of
garlicextractonnaturalkilleractivity,” InternationalImmuno-
pharmacology, vol. 3, no. 10-11, pp. 1483–1489, 2003.
[16] G. Wang, J. Zhao, J. Liu, Y. Huang, J.-J. Zhong, and W. Tang,
“Enhancement of IL-2 and IFN-γ expression and NK cells
activity involved in the anti-tumor eﬀect of ganoderic acid Me
in vivo,” International Immunopharmacology, vol. 7, no. 6, pp.
864–870, 2007.
[17] M. Pathak, N. Bano, P. Dixit et al., “Immunosuppressive
activity of hexane and ethanolic extracts of Pterospermum
acerifolium seeds in BALB/c mice,” Medicinal Chemistry
Research. In press.
[18] J. Walewski, E. Paietta, J. Dutcher, and P. H. Wiernik,
“Evaluation of natural killer and lymphokine-activated killer
(LAK) cell activity in vivo in patients treated with high-dose
interleukin-2 and adoptive transfer of autologous LAK cells,”
Journal of Cancer Research and Clinical Oncology, vol. 115, no.
2, pp. 170–174, 1989.
[19] W. J. Murphy and D. L. Longo, “NK cells in the regulation of
hematopoiesis,” Methods, vol. 9, no. 2, pp. 344–351, 1996.
[20] W. J. Murphy, J. R. Keller, C. L. Harrison, H. A. Young,
a n dD .L .L o n g o ,“ I n t e r l e u k i n - 2 - a c t i v a t e dn a t u r a lk i l l e rc e l l s
can support hematopoiesis in vitro and promote marrow
engraftment in vivo,” Blood, vol. 80, no. 3, pp. 670–677, 1992.
[21] P.-L. Wang and T. P. Johnston, “Sustained-release interleukin-
2 following intramuscular injection in rats,” International
Journal of Pharmaceutics, vol. 113, no. 1, pp. 73–81, 1995.
[22] S. K. Yeap, N. B. M. Alitheen, W. Y. Ho et al., “Immunomod-
ulatory role of Rhaphidophora korthalsii methanol extract
on human peripheral blood mononuclear cell proliferation,
cytokine secretion and cytolytic activity,” Journal of Medicinal
Plants Research, vol. 5, no. 6, pp. 958–965, 2011.
[23] G. Dranoﬀ,“ Cytokines in cancer pathogenesis and cancer
therapy,” Nature Reviews Cancer, vol. 4, no. 1, pp. 11–22, 2004.